A Phase II Study of MEDI-507, Administered by Injection to Adults With Psoriasis

Clinical trial NCT00540618 · COMPLETED

Trial details

NCT number: NCT00540618
Sponsor: MedImmune LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Plaque Psoriasis

Start date: 2001-09-01
Enrollment: 420

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.